L. Roy Papp & Associates’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.33M Sell
6,448
-9
-0.1% -$3.08K 0.25% 63
2026
Q1
$2.27M Hold
6,457
0.26% 63
2025
Q4
$2.11M Hold
6,457
0.23% 67
2025
Q3
$1.82M Sell
6,457
-1
-0% -$290 0.2% 70
2025
Q2
$1.8M Hold
6,458
0.21% 73
2025
Q1
$2.01M Hold
6,458
0.25% 65
2024
Q4
$1.68M Hold
6,458
0.2% 76
2024
Q3
$2.08M Hold
6,458
0.25% 66
2024
Q2
$2.02M Buy
6,458
+1
+0% +$294 0.24% 69
2024
Q1
$1.84M Buy
6,457
+241
+4% +$70.5K 0.22% 75
2023
Q4
$1.79M Hold
6,216
0.22% 72
2023
Q3
$1.67M Sell
6,216
-655
-10% -$163K 0.23% 71
2023
Q2
$1.53M Hold
6,871
0.2% 79
2023
Q1
$1.66M Hold
6,871
0.22% 76
2022
Q4
$1.8M Sell
6,871
-826
-11% -$221K 0.25% 73
2022
Q3
$1.74M Sell
7,697
-60
-0.8% -$14.5K 0.26% 74
2022
Q2
$1.89M Buy
7,757
+59
+0.8% +$14.5K 0.27% 70
2022
Q1
$1.86M Sell
7,698
-640
-8% -$147K 0.23% 76
2021
Q4
$1.88M Sell
8,338
-940
-10% -$198K 0.21% 79
2021
Q3
$1.97M Sell
9,278
-700
-7% -$161K 0.25% 71
2021
Q2
$2.43M Buy
9,978
+992
+11% +$244K 0.31% 63
2021
Q1
$2.24M Sell
8,986
-2,008
-18% -$479K 0.32% 67
2020
Q4
$2.53M Sell
10,994
-1,221
-10% -$282K 0.29% 63
2020
Q3
$3.1M Buy
12,215
+100
+0.8% +$24.8K 0.4% 58
2020
Q2
$2.86M Sell
12,115
-68
-0.6% -$15.5K 0.4% 56
2020
Q1
$2.47M Sell
12,183
-213
-2% -$46.5K 0.45% 53
2019
Q4
$2.99M Buy
12,396
+13
+0.1% +$2.87K 0.43% 54
2019
Q3
$2.4M Sell
12,383
-157
-1% -$30.1K 0.38% 61
2019
Q2
$2.31M Buy
12,540
+530
+4% +$94.9K 0.36% 62
2019
Q1
$2.28M Sell
12,010
-556
-4% -$106K 0.41% 55
2018
Q4
$2.45M Buy
12,566
+447
+4% +$87.2K 0.51% 45
2018
Q3
$2.51M Sell
12,119
-100
-0.8% -$19.7K 0.45% 47
2018
Q2
$2.26M Sell
12,219
-1,255
-9% -$222K 0.43% 54
2018
Q1
$2.3M Buy
13,474
+4,274
+46% +$785K 0.44% 54
2017
Q4
$1.6M Buy
9,200
+420
+5% +$74.3K 0.32% 62
2017
Q3
$1.64M Sell
8,780
-498
-5% -$88.2K 0.35% 58
2017
Q2
$1.6M Hold
9,278
0.35% 62
2017
Q1
$1.52M Sell
9,278
-151
-2% -$25.1K 0.35% 61
2016
Q4
$1.38M Sell
9,429
-250
-3% -$37.6K 0.32% 67
2016
Q3
$1.61M Buy
9,679
+1,159
+14% +$196K 0.37% 61
2016
Q2
$1.3M Sell
8,520
-76
-0.9% -$11.8K 0.31% 69
2016
Q1
$1.29M Hold
8,596
0.31% 68
2015
Q4
$1.4M Sell
8,596
-310
-3% -$48.7K 0.34% 63
2015
Q3
$1.23M Sell
8,906
-1,256
-12% -$198K 0.3% 64
2015
Q2
$1.56M Buy
10,162
+2,948
+41% +$472K 0.35% 62
2015
Q1
$1.15M Buy
7,214
+379
+6% +$59.7K 0.25% 77
2014
Q4
$1.09M Sell
6,835
-1,025
-13% -$160K 0.24% 79
2014
Q3
$1.1M Sell
7,860
-200
-2% -$26.1K 0.26% 77
2014
Q2
$954K Sell
8,060
-1,103
-12% -$128K 0.21% 84
2014
Q1
$1.13M Sell
9,163
-3,513
-28% -$426K 0.26% 74
2013
Q4
$1.45M Sell
12,676
-81
-0.6% -$9.21K 0.31% 63
2013
Q3
$1.43M Sell
12,757
-155
-1% -$16.8K 0.34% 61
2013
Q2
$1.27M Buy
+12,912
New +$1.34M 0.32% 64

Other funds holding AMGN

L. Roy Papp & Associates's AMGN Position: Q2 2026 in Review

L. Roy Papp & Associates reduced its Amgen (AMGN) stake by 0.14% in Q2 2026, selling an estimated $3.08K and leaving 6,448 shares worth $2.33M. The position accounts for 0.25% of the portfolio, ranked #63.

L. Roy Papp & Associates first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.1M in Q3 2020. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • L. Roy Papp & Associates held 6,448 shares of Amgen worth $2.33M as of Q2 2026.
  • L. Roy Papp & Associates sold 9 Amgen shares in Q2 2026, an estimated $3.08K.
  • Amgen made up 0.25% of L. Roy Papp & Associates's portfolio in Q2 2026, its #63 holding.
  • L. Roy Papp & Associates first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • L. Roy Papp & Associates's Amgen position peaked at $3.1M in Q3 2020.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on L. Roy Papp & Associates's 13F filing for Q2 2026, filed 23 Jul 2026.